Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 14 studies | 27% ± 9% | |
epithelial cell of proximal tubule | 7 studies | 32% ± 8% | |
hepatocyte | 5 studies | 53% ± 24% | |
secretory cell | 3 studies | 20% ± 3% | |
epithelial cell | 3 studies | 30% ± 5% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
liver | 3 studies | 24% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 7898.00 | 226 / 226 | 95% | 122.89 | 384 / 406 |
kidney | 100% | 2038.64 | 89 / 89 | 85% | 45.83 | 762 / 901 |
prostate | 84% | 211.42 | 207 / 245 | 96% | 23.05 | 482 / 502 |
thymus | 89% | 130.33 | 578 / 653 | 79% | 12.99 | 477 / 605 |
pancreas | 100% | 294.73 | 328 / 328 | 46% | 6.55 | 82 / 178 |
intestine | 54% | 560.90 | 523 / 966 | 92% | 29.66 | 484 / 527 |
lung | 78% | 178.25 | 452 / 578 | 68% | 12.31 | 782 / 1155 |
adrenal gland | 97% | 1573.45 | 250 / 258 | 43% | 9.15 | 98 / 230 |
stomach | 47% | 39.40 | 169 / 359 | 88% | 22.52 | 253 / 286 |
bladder | 48% | 142.95 | 10 / 21 | 77% | 18.62 | 387 / 504 |
breast | 53% | 127.23 | 242 / 459 | 59% | 27.92 | 662 / 1118 |
esophagus | 42% | 87.42 | 603 / 1445 | 61% | 11.21 | 112 / 183 |
ureter | 0% | 0 | 0 / 0 | 100% | 12.32 | 1 / 1 |
brain | 68% | 113.68 | 1799 / 2642 | 1% | 0.09 | 8 / 705 |
adipose | 56% | 165.99 | 680 / 1204 | 0% | 0 | 0 / 0 |
skin | 53% | 62.58 | 955 / 1809 | 4% | 0.27 | 17 / 472 |
uterus | 6% | 19.41 | 10 / 170 | 50% | 9.19 | 230 / 459 |
peripheral blood | 48% | 59.89 | 445 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 45% | 4.52 | 13 / 29 |
tonsil | 0% | 0 | 0 / 0 | 24% | 2.74 | 11 / 45 |
spleen | 22% | 26.62 | 52 / 241 | 0% | 0 | 0 / 0 |
ovary | 7% | 4.64 | 13 / 180 | 11% | 0.98 | 48 / 430 |
blood vessel | 2% | 1.46 | 25 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 1% | 0.07 | 1 / 80 |
muscle | 0% | 0.18 | 1 / 803 | 0% | 0 | 0 / 0 |
heart | 0% | 0.09 | 1 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0008206 | Biological process | bile acid metabolic process |
GO_0097089 | Biological process | methyl-branched fatty acid metabolic process |
GO_0001561 | Biological process | fatty acid alpha-oxidation |
GO_0042760 | Biological process | very long-chain fatty acid catabolic process |
GO_0044539 | Biological process | long-chain fatty acid import into cell |
GO_0001676 | Biological process | long-chain fatty acid metabolic process |
GO_0006699 | Biological process | bile acid biosynthetic process |
GO_0006635 | Biological process | fatty acid beta-oxidation |
GO_0046949 | Biological process | fatty-acyl-CoA biosynthetic process |
GO_0005778 | Cellular component | peroxisomal membrane |
GO_0035579 | Cellular component | specific granule membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0005829 | Cellular component | cytosol |
GO_0019899 | Molecular function | enzyme binding |
GO_0005324 | Molecular function | long-chain fatty acid transmembrane transporter activity |
GO_0015245 | Molecular function | fatty acid transmembrane transporter activity |
GO_0031957 | Molecular function | very long-chain fatty acid-CoA ligase activity |
GO_0004467 | Molecular function | long-chain fatty acid-CoA ligase activity |
GO_0047747 | Molecular function | cholate-CoA ligase activity |
GO_0070251 | Molecular function | pristanate-CoA ligase activity |
GO_0047676 | Molecular function | arachidonate-CoA ligase activity |
GO_0005524 | Molecular function | ATP binding |
GO_1901480 | Molecular function | oleate transmembrane transporter activity |
GO_0050197 | Molecular function | phytanate-CoA ligase activity |
Gene name | SLC27A2 |
Protein name | long-chain-fatty-acid--CoA ligase (EC 6.2.1.3) (Long-chain-fatty-acid--CoA ligase) Long-chain fatty acid transport protein 2 (Arachidonate--CoA ligase) (EC 6.2.1.15) (Fatty acid transport protein 2) (FATP-2) (Fatty-acid-coenzyme A ligase, very long-chain 1) (Long-chain-fatty-acid--CoA ligase) (EC 6.2.1.3) (Phytanate--CoA ligase) (EC 6.2.1.24) (Solute carrier family 27 member 2) (THCA-CoA ligase) (EC 6.2.1.7) (Very long-chain acyl-CoA synthetase) (VLACS) (VLCS) (EC 6.2.1.-) (Very long-chain-fatty-acid-CoA ligase) |
Synonyms | ACSVL1 FATP2 VLACS hCG_39815 FACVL1 |
Description | FUNCTION: Mediates the import of long-chain fatty acids (LCFA) into the cell by facilitating their transport across cell membranes, playing an important role in hepatic fatty acid uptake . Also functions as an acyl-CoA ligase catalyzing the ATP-dependent formation of fatty acyl-CoA using LCFA and very-long-chain fatty acids (VLCFA) as substrates, which prevents fatty acid efflux from cells and might drive more fatty acid uptake . Plays a pivotal role in regulating available LCFA substrates from exogenous sources in tissues undergoing high levels of beta-oxidation or triglyceride synthesis . Can also activate branched-chain fatty acids such as phytanic acid and pristanic acid . May contribute to the synthesis of sphingosine-1-phosphate . Does not activate C24 bile acids, cholate and chenodeoxycholate . In vitro, activates 3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholestanate (THCA), the C27 precursor of cholic acid deriving from the de novo synthesis from cholesterol . However, it is not critical for THCA activation and bile synthesis in vivo . .; FUNCTION: [Isoform 1]: Exhibits both long-chain fatty acids (LCFA) transport activity and acyl CoA synthetase towards very long-chain fatty acids . Shows a preference for generating CoA derivatives of n-3 fatty acids, which are preferentially trafficked into phosphatidylinositol . .; FUNCTION: [Isoform 2]: Exhibits long-chain fatty acids (LCFA) transport activity but lacks acyl CoA synthetase towards very long-chain fatty acids. . |
Accessions | ENST00000380902.8 [O14975-2] G3V1R7 ENST00000267842.10 [O14975-1] O14975 ENST00000544960.1 |